市場調査レポート

商品コード

1701126

膝の腫れ治療の市場規模、シェア、成長分析、タイプ別、薬物療法別、手術別、エンドユーザー別、地域別 - 産業予測 2025年～2032年

Swollen Knee Treatment Market Size, Share, and Growth Analysis, By Type (Medications, Patient-controlled Analgesia Pumps), By Medications (Opioids, Corticosteroids), By Surgery, By End User, By Region - Industry Forecast 2025-2032

出版日: 2025年04月01日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 774,224円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 905,696円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,037,168円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.08円

全表示
概要
目次

概要

サンプル依頼リストに入れる

膝の腫れ治療市場規模は2023年に20億9,000万米ドルと評価され、2024年の21億8,000万米ドルから2032年には31億1,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは4.5％で成長する見通しです。

膝の腫れ治療市場は、非外科的ヘルスケアソリューションへの顕著な動向に起因する成長課題に遭遇する可能性が高いです。患者は、従来の外科的選択肢よりも治療や準備的治療を好むようになっており、低侵襲・非侵襲的アプローチへのシフトを示しています。人工膝関節置換術を含む外科的治療に伴う潜在的な副作用や合併症に対する意識の高まりが、患者の嗜好の変化を促しています。外科的処置のリスクについての知識が深まるにつれ、侵襲が少なく、回復が早く、同様の効果が得られる代替法を積極的に求めるようになっています。このような情勢の変化により、より安全で保存的な治療法を求める患者の嗜好に沿った市場戦略の再評価が必要となっています。

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2024年）
主な市場企業が採用した戦略
最近の市場動向
企業の市場シェア分析（2024年）
主要企業の企業プロファイル
- 企業の詳細
- 製品ポートフォリオ分析
- 企業のセグメント別シェア分析
- 収益の前年比比較（2022-2024年）

主要企業プロファイル

Stryker Corporation（USA）
Ossur（Iceland）
Smith & Nephew（United Kingdom）
Zimmer Biomet（USA）
Arthrex（USA）
DJO Global（USA）
Medacta International（Switzerland）
B. Braun Melsungen（Germany）
Exactech（USA）
Wright Medical Group（USA）
Corin Group（United Kingdom）
MicroPort Orthopedics（China）
Aesculap Implant Systems（Germany）
Tornier N.V.（Netherlands）
Bioventus（USA）
Pfizer（USA）
Novartis（Switzerland）

結論と提言

Product Code: SQMIG35A2820

Swollen Knee Treatment Market size was valued at USD 2.09 billion in 2023 and is poised to grow from USD 2.18 billion in 2024 to USD 3.11 billion by 2032, growing at a CAGR of 4.5% during the forecast period (2025-2032).

The swollen knee treatment market is likely to encounter growth challenges stemming from a noticeable trend towards non-surgical healthcare solutions. Patients are increasingly favoring therapeutic and preparatory treatments over traditional surgical options, demonstrating a shift towards minimally invasive and non-invasive approaches. Heightened awareness of the potential side effects and complications associated with surgical treatments, including knee arthroplasty, is driving this change in patient preferences. As individuals become more educated about the risks of surgical procedures, they are actively seeking alternative methods that provide similar effectiveness with less invasiveness and quicker recovery times. This evolving landscape necessitates a reevaluation of market strategies to align with the patients' preferences for safer and more conservative treatment options.

Top-down and bottom-up approaches were used to estimate and validate the size of the Swollen Knee Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Swollen Knee Treatment Market Segments Analysis

Global Swollen Knee Treatment Market is segmented by Type, Medications, Surgery, End User and region. Based on Type, the market is segmented into Medications, Patient-controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery. Based on Medications, the market is segmented into Opioids, Corticosteroids and Others. Based on Surgery, the market is segmented into Arthrocentesis, Arthroscopy and Knee Replacement. Based on End User, the market is segmented into Hospitals, Designated Clinics, Ambulatory Surgical Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Swollen Knee Treatment Market

One of the key market drivers for the global swollen knee treatment market is the rising prevalence of knee-related disorders, such as osteoarthritis, rheumatoid arthritis, and sports injuries among the aging population. As the global demographic shifts towards an older population, the incidence of knee problems is increasing, necessitating effective treatment options. Additionally, lifestyle factors such as obesity and increased physical activity contribute to knee joint stress, leading to a higher demand for medical interventions. These factors, combined with advancements in treatment technologies and a growing emphasis on preventive care, are fueling the expansion of the swollen knee treatment market.

Restraints in the Swollen Knee Treatment Market

The Swollen Knee Treatment market faces significant restraints, primarily due to the financial barriers associated with advanced treatment options like knee replacement surgery. The total expenses for such procedures can be substantial, covering pre-operative evaluations, the surgery itself, post-operative care, and rehabilitation costs. These financial burdens can limit access for patients who may already be struggling with economic constraints, making it difficult for them to benefit from vital surgical interventions. Consequently, addressing these financial challenges is crucial to reducing healthcare disparities and ensuring equitable access to essential medical treatments for all individuals, regardless of their financial situation.

Market Trends of the Swollen Knee Treatment Market

The Swollen Knee Treatment market is witnessing a significant upward trend driven by advancements in medical device technology specifically tailored for knee-related solutions. Innovations in knee braces, supports, and orthotic implants are transforming treatment approaches for various orthopedic conditions, resulting in enhanced patient comfort and therapeutic outcomes. These state-of-the-art devices offer targeted support, stability, and optimal alignment, catering to a diverse range of knee issues, from acute injuries to chronic ailments. This continuous evolution not only enriches the treatment landscape but also empowers healthcare professionals to customize interventions, thereby meeting individual patient needs and enhancing the overall quality of care in the market.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Swollen Knee Treatment Market Size by Type & CAGR (2025-2032)

Market Overview
Medications
Patient-controlled Analgesia Pumps
Nerve Blocks
Liposomal Bupivacaine
Surgery

Global Swollen Knee Treatment Market Size by Medications & CAGR (2025-2032)

Market Overview
Opioids
Corticosteroids
Others

Global Swollen Knee Treatment Market Size by Surgery & CAGR (2025-2032)

Market Overview
Arthrocentesis
Arthroscopy
Knee Replacement
- Total Knee Replacement
- Unicompartmental Knee Replacement
- Others

Global Swollen Knee Treatment Market Size by End User & CAGR (2025-2032)

Market Overview
Hospitals
Designated Clinics
Ambulatory Surgical Centers
Others

Global Swollen Knee Treatment Market Size & CAGR (2025-2032)

North America (Type, Medications, Surgery, End User)
- US
- Canada
Europe (Type, Medications, Surgery, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Medications, Surgery, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Medications, Surgery, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Medications, Surgery, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Stryker Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ossur (Iceland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smith & Nephew (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zimmer Biomet (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Arthrex (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DJO Global (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medacta International (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Exactech (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Wright Medical Group (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Corin Group (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroPort Orthopedics (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aesculap Implant Systems (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tornier N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioventus (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

膝の腫れ治療の市場規模、シェア、成長分析、タイプ別、薬物療法別、手術別、エンドユーザー別、地域別 - 産業予測 2025年～2032年

Swollen Knee Treatment Market Size, Share, and Growth Analysis, By Type (Medications, Patient-controlled Analgesia Pumps), By Medications (Opioids, Corticosteroids), By Surgery, By End User, By Region - Industry Forecast 2025-2032

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

膝の腫れ治療市場規模：タイプ別& CAGR（2025-2032）

膝の腫れ治療市場規模：薬物療法別& CAGR（2025-2032）

膝の腫れ治療市場規模：手術別& CAGR（2025-2032）

膝の腫れ治療市場規模：エンドユーザー別& CAGR（2025-2032）

膝の腫れ治療市場規模：地域別& CAGR（2025-2032）